CausalSentinel

Protein Dossier — RNASE6 (Ribonuclease K6)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: joint disorder 0.104 0.0375 0.00549 Wald ratio 1 cis NA
Autism -0.0889 0.0328 0.00673 Wald ratio 1 cis NA
Sleep duration 0.00555 0.00223 0.0126 Wald ratio 1 cis NA
Depressive symptoms -0.00903 0.00401 0.0244 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pulmonary embolism (with or without) dvt -0.0747 0.0341 0.0285 Wald ratio 1 cis NA
Knee osteoarthritis 0.0679 0.031 0.0285 Wald ratio 1 cis NA
Triglycerides 0.0134 0.00622 0.0307 Wald ratio 1 cis NA
Caudate volume -12.1 5.65 0.0329 Wald ratio 1 cis NA
Height -0.00822 0.00391 0.0355 Wald ratio 1 cis NA
Non-cancer illness code self-reported: psoriasis -0.0591 0.0285 0.0381 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) 0.00509 0.00247 0.0392 Wald ratio 1 cis NA
Parkinson’s disease -0.0956 0.0472 0.0427 Wald ratio 1 cis NA
…and 94 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

13 association rows across 12 traits (12 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Ribonuclease K6 levels 4e-2405 rs72669422 2 GCST90249345 no MR -> candidate analysis
Ribonuclease K6 levels (RNASE6.5646.20.3) 6e-391 rs11622942 1 GCST90242668 no MR -> candidate analysis
Serum levels of protein RNASE6 2e-306 rs1045922 1 GCST90089118 no MR -> candidate analysis
EDDM3B protein levels 2e-193 rs12586813 1 GCST90469069 no MR -> candidate analysis
Blood protein levels 4e-164 rs2319516 1 GCST006585 no MR -> candidate analysis
RNAS6 protein level (protein group normalized intensity) 4e-52 rs11622942 1 GCST90570754 no MR -> candidate analysis
Monocyte side fluorescence 1e-45 rs1045922 1 GCST90281241 no MR -> candidate analysis
Ribonuclease K6 level in Chronic kidney disease with hyperte 8e-40 rs1045922 1 GCST90238009 no MR -> candidate analysis
Tumor necrosis factor receptor superfamily member 18 protein 3e-26 rs11623935 1 GCST90437249 no MR -> candidate analysis
RNASE6 protein levels 1e-14 rs112015241 1 GCST90470479 no MR -> candidate analysis
Gamma-crystallin C levels 1e-14 rs11622942 1 GCST90423176 no MR -> candidate analysis
Liver RNASE6 levels 5e-7 rs1045922 1 GCST90802741 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 108 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
skin cancer 0.259 common-variant locus no MR -> candidate analysis

Of the 1 rows above, 1 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=NA, LOEUF=NA — Constraint metrics missing; LoF tolerance cannot be judged.
GWAS Catalog 89 unique SNPs / 178 rows
ClinVar 56 records; 4 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance